OBJECTIVE: For the premature infant, extrauterine life is a pathological condition, which greatly amplifies the challenges to the brain in establishing functional oromotor behaviors. The extent to which suck can be entrained using a synthetically patterned orocutaneous input to promote its development in preterm infants who manifest chronic lung disease (CLD) is unknown. The objective of this study was to evaluate the effects of a frequency-modulated (FM) orocutaneous pulse train delivered through a pneumatically charged pacifier capable of enhancing non-nutritive suck (NNS) activity in tube-fed premature infants. STUDY DESIGN: A randomized trial to evaluate the efficacy of pneumatic orocutaneous stimulation 3 Â per day on NNS development and length of stay (LOS) in the neonatal intensive care unit among 160 newborn infants distributed among three subpopulations, including healthy preterm infants, respiratory distress syndrome (RDS) and CLD. Study infants received a regimen of orocutaneous pulse trains through a PULSED pressurized silicone pacifier or a SHAM control (blind pacifier) during gavage feeds for up to 10 days. RESULT: Mixed modeling, adjusted for the infant's gender, gestational age, postmenstrual age and birth weight, was used to handle interdependency among repeated measures within subjects. A significant main effect for stimulation mode (SHAM pacifier vs PULSED orosensory) was found among preterm infants for NNS bursts per min (P ¼ 0.003), NNS events per min (P ¼ 0.033) and for total oral compressions per min (NNS þ nonNNS) (P ¼ 0.016). Pairwise comparison of adjusted means using Bonferroni adjustment indicated RDS and CLD infants showed the most significant gains on these NNS performance indices. CLD infants in the treatment group showed significantly shorter LOS by an average of 2.5 days. CONCLUSION: FM PULSED orocutaneous pulse train stimuli delivered through a silicone pacifier are effective in facilitating NNS burst development in tube-fed RDS and CLD preterm infants, with an added benefit of reduced LOS for CLD infants.
INTRODUCTION
Feeding competency is a frequent and serious challenge both to infants in the neonatal intensive care unit (NICU) and to their caregivers, health-care staff and parents. 1 One of the first steps used by clinicians toward achieving ororhythmic patterning and assessment of feeding readiness involves the use of a finger or a silicone pacifier to induce non-nutritive suckling (NNS). 1 This ororhythmic behavior appears between 28 and 33 weeks of gestational age (GA) and is remarkably stable by 34 weeks of postmenstrual age (PMA). 2 Suck represents a complex sensorimotor behavior that can provide valuable insights into the integrity of the central nervous system in the human infant. 3, 4 Establishing the NNS provides the infant with numerous benefits, including improved pre-feed state control [5] [6] [7] and postfeed 8 growth, maturation, gastric motility, while decreasing stress 5, 8, 9 and enhancing oral feeds. 10 NNS also has been shown to decrease the length of hospital stay in preterm infants, and in general there are no known short-term negative side effects. 11 NNS may also allow critical aspects of oromotor and feeding development to progress through stimulation and to reduce the length of time spent on nasogastric tube feeding. [12] [13] [14] [15] Preterm infants born between 24 and 34 weeks of GA with higher NNS scores had a 3-day shorter transition to full oral feeds compared with infants with disorganized NNS. 16 GA at birth was inversely related with PMA at full oral feeds.
The purpose of the present investigation was to assess the effects of a new frequency-modulated (FM) orocutaneous intervention in tube-fed preterm infants on the development of NNS and length of stay (LOS) in three sub-populations, two of which are at significant risk for oromotor and feeding delays. It was hypothesized that repeated application of an FM orocutaneous stimulus that mimics the 'burst-pause' temporal dynamics of NNS would accelerate the development of this complex ororhythmic behavior, and potentially reduce the length of hospital stay.
METHODS

Study population
A randomized controlled trial design was used to evaluate the efficacy of pulsed orocutaneous stimulation on NNS development and LOS among 162 newborn infants (73F/89M) distributed among 3 sub-populations, including an initial enrollment of 49 healthy preterm infants (HIs), 39 with respiratory distress syndrome (RDS) and 74 whose respiratory condition evolved into chronic lung disease (CLD; Power ¼ 0.80, Po0.05). A total of two infants dropped out of the study following enrollment because of the development of necrotizing enterocolitis, a criterion for exclusion from our study (group assignments: RDS treatment and HI treatment). For two infants in the study, gastrostomy tubes (g-tubes) were placed following hospital discharge or transfers to other NICUs in the Kansas area. Each of these infants had a diagnosis of CLD (one control and one treatment). Participant characteristics for the 160 preterm infants analyzed in this study are given in Table 1 . The human subjects committee at each performance site, including the Overland Park Regional Medical Center (Overland Park, KS USA) and Stormont-Vail HealthCare (Topeka, KS, USA) approved the research protocol for this study. Written informed consent was obtained from the parents at each NICU before the participants' enrollment into the study following consultation with the attending physician and the research nurse or study coordinator dedicated full-time to this project. Medical staff involved in nursing care of study participants were blinded to treatment condition for the duration of the intervention protocol. Newborn infants among each of the three clinical populations were randomly assigned to either the PULSED orocutaneous stimulation or the SHAM 'non-pulsatile' pacifier using a random integer number function. The expected ethnic proportion for Kansas, based on the US Federal Census was African American 5.8%, Asian American 1.7%, Hispanic American 5.5%, Native American 0.8% and White 86.2%.
Inclusion criteria for specific treatment groups. For HI, RDS and CLD infants: born between 23 0/7 and 36 6/7 weeks of GA as determined by obstetric ultrasound and clinical examination. HI designates preterm infants (N ¼ 48; 23 treatment, 25 control) with no specific diagnosis who were otherwise medically stable, and who had minimal or no oxygen history (p 5 days of ventilator, continuous positive airway pressue and nasal cannula). RDS infants (N ¼ 38; 18 treatment, 20 control) had a diagnosis of RDS confirmed by X-ray earlier in their hospital stay and required respiratory support with oxygen (days on ventilator þ continuous positive airway pressue þ nasal cannula) that was no longer necessary by 28 days of age or 36 weeks PMA. CLD includes sicker preterm infants (N ¼ 74; 32 treatment, 42 control) who still required respiratory support with oxygen at 36 weeks PMA.
General inclusion criteria.
No functional suck and tube-fed at time of enrollment, head circumference within 10 to 90th percentile of mean for PMA, neurological examination showing no anomalies for PMA, and with stable vital signs (heart rate, blood pressure, age appropriate respiratory rate and oxygen saturation 492 SpO 2 ) to allow for NNS.
General exclusion criteria. Intraventricular hemorrhage grades III or IV, other intracranial hemorrhage, periventricular leukomalacia, necrotizing enterocolitis, neonatal seizures and culture positive sepsis or meningitis at time of testing, chromosomal anomalies or craniofacial malformation, nervous system anomalies, cyanotic congenital heart disease, gastroschisis, omphalocele, diaphragmatic hernia and/or other major gastrointestinal anomalies, or not ready for oral feedings as determined by the health care team.
PULSED pneumatic orocutaneous and SHAM stimulation conditions
Infants assigned to the PULSED treatment group received three 3-min epochs of pneumatically pulsed pacifier stimulation during gavage feeds using the NTrainer System (Innara Health, Olathe, KS USA). This PULSED stimulus was programmed to mimic the temporal features of a NNS burst. Each 3-min stimulation epoch consisted of 34 oral cutaneous pulse trains. The 3-min PULSED stimulation periods were separated by 5.5-min pause periods during which the stimulator was switched off and the pneumatically charged pacifier was removed from the infant's mouth (see Table 2 ).
Infants assigned to the SHAM treatment were offered the same type of Soothie pacifier for the same duration but without the pneumatically patterned stimulus. Figure 1 shows the NTrainer handpiece and silicone pacifier assembly with an infant as used for the SHAM or PULSED conditions.
The treatment regimen for both SHAM and PULSED pacifier conditions was repeated three times per day for up to 10 days according to their 3-h feed cycles, or until the infant attained 90% oral feeds at a volume of 140 to 160 ml kg -1 day -1 for 2 consecutive days. Infants were swaddled with limbs at midline, and in a quiet-awake to drowsy state during stimulation. 17 Observers in the NICU could not differentiate which babies received the pulsed orocutaneous stimulation as the same cribside NTrainer System workstation was used for NNS assessment and treatment conditions.
Advancement to oral feeding
All infants in the study, regardless of their assignment to either the NTrainer or the Control group, were fed with the Volu-feed disposable nurser-Strong Babies System (Abbott Laboratories, Abbott Park, IL, USA) in combination with periodic breast feeding attempts. The percentage of Table 1 . Preterm infant characteristics (mean (s.d.))
Gender FM orocutaneous stimulation promotes NNS development SM Barlow et al infants among the HI, RDS and CLD groups who attempted breastfeeding was 54.2%, 54.3% and 47.2%, respectively. Infants were monitored by their nurses and physicians for pulse and O 2 saturation (pulse-oximetry), along with respiration patterns during feeds for safety. Infants were allowed to attempt oral feeds as long as their SpO 2 levels were maintained at or above 92%, and heart rate was stable. Babies exhibiting O 2 desaturations, breathing difficulties, spit-ups, postural distress and bradycardia during oral feed attempts were then fed by nasogastric tube. Nutritional content was specific to each infant as ordered by the physician to satisfy caloric demands.
NNS progression
The evolution of the NNS compression pressure waveform was documented through daily 3-min digital recordings completed at the beginning of a gavage feed. During these NNS recording sessions, infants did not receive the pulsed orocutaneous stimulation. Infants remained connected to their bedside monitors at all times for observation of respiration, heartbeat and oxygen saturation. The same Soothie silicone pacifier type used during the stimulation sessions was coupled to the NTrainer handpiece, which was instrumented to record nipple pressure and permitted the study nurse to start and stop computer program operation.
Following a brief examination of physiologic state, each infant, regardless of group, was held in a developmentally supportive semiinclined posture. Background/overhead lighting was dimmed in the immediate area to promote eye contact with the nurse/study coordinator. Sampling of NNS behavior was not initiated until the infant achieved an optimal behavioral state, that is, drowsy to active alert (state 3, 4 or 5 as described by the Naturalistic Observation of Newborn Behavior, Newborn Individualized Developmental Care and Assessment Program; NIDCAP). 17 Automated NNS digital signal processing and feature extraction A 2-min subsample reflecting the most active period of NNS oromotor behavior was automatically extracted from each 3-min suck assessment data file using a custom software algorithm on the NTrainer System. An NNS burst was defined as two or more NNS events occurring within 1200 ms. If this amount of time is exceeded, then a new NNS burst is classified. This algorithm permits objective identification of NNS burst activity as distinct from non-organized mouthing compressions. A detailed description of the NNS burst software algorithm is included in the online supplementary. Five measures were extracted from the indexed records of suck, including: (1) total oral compressions defined as the sum of all pressure events per minute, (2) NNS cycles defined as suck compression cycles with cycle periods o1200 ms and occurring within the NNS burst structure per minute, (3) the number of NNS bursts, which consisted of two or more nipple compression cycles. The two remaining NNS performance measures included the (4) mean number NNS cycles/burst and (5) NNS pressure amplitude (cmH 2 O).
Statistical analysis
The primary end points included a longitudinal comparison of NNS performance and LOS between the two treatments (SHAM and PULSED), each consisting of three preterm infant groups (HI, RDS and CLD). Mixed modeling was used to handle interdependency among repeated measures within subjects. Adjusting for the infants' gender, GA, PMA and birth weight, mixed models estimated (linear) growth over time as well as stimulus group, infant group, and their interaction effects on each outcome, using restricted maximum likelihood estimator, which produces unbiased estimates under the conditions of unbalanced sample and/or incomplete data. Adjusted means were pairwise compared using Bonferroni adjustment for inflated type I error. A compound symmetric error covariance structure provided better model fit than other error covariance structures according to Akaike Information Criterion and Bayesian Information Criterion and thus was chosen for the mixed models. All analyses were conducted using SAS 9.3. 18
RESULTS
The PULSED orocutaneous stimuli delivered through a silicone pacifier was effective in facilitating NNS burst development in tube-fed preterm infants. Within each group, no substantial deviation from normality was found for any of the dependent variables. The assumptions of normality, linearity, homogeneity of variance-covariance matrices and sphericity were satisfactory for the multivariate analysis.
Distribution of GA birth and treatment start among preterm groups The resulting distribution of preterm infants for the three preterm populations exposed to either of the treatment conditions is shown in Figure 2 . HI infants began the treatment at 20.6 days of age (mean GA birth ¼ 222.1 days), whereas RDS infants, who were born approximately 1 week earlier (mean GA birth ¼ 214.5 days), began treatment at 27.0 days of age. CLD infants were born the earliest (mean GA birth ¼ 188.1 days) and began the orosensory treatments at 61.4 days of age. Within preterm groups, there were no significant differences in GA birth or the PMA at the start of treatment conditions, however, the starting PMA for the treatment conditions between preterm infant groups was significantly different (F(1, 157) , Po0.0001) and as shown follows a logical progression from HI4RDS4CLD.
NNS bursts per min
A significant main effect for treatment condition (SHAM pacifier vs PULSED pacifier) was found among preterm infants independent of clinical group (Po0.001, d ¼ 0.58). For all preterm groups combined, this translates to a 17.2% increase from 7.67 to 8.99 NNS bursts per min. As shown in Figure 3 , the adjusted means from the mixed model showed an increase of 12.5% from 7.20 (SHAM) to 8.10 NNS bursts per min in the presence of the PULSED pacifier entrainment condition. RDS infants exposed to the PULSED treatment condition showed an increase of 20.7%, 7.62 to 9.20 NNS bursts per min (Po0.05, d ¼ 0.36). Infants with CLD also showed moderate gains from the treatment condition with an increase of 17.9% from 8.19 NNS bursts per min (SHAM) to 9.66 NNS bursts per min during the PULSED entrainment condition (Po0.01, d ¼ 0.46).
NNS events per min
A significant main effect for treatment condition was found among preterm subjects independent of clinical group (Po0.05, d ¼ 0.36). For all preterm groups combined, this translates to a 17.2% increase from 65.6 to 73.0 NNS events per min. As shown in Figure 4 , CLD infants showed the most significant gains from the treatment condition with an increase of 15.0% from 68.75 NNS events per min (SHAM) to 79.04 NNS events per min for PULSED stimulation (Po0.05, d ¼ 0.42). Moreover, CLD babies outpaced HIs by 20.7% in the PULSED treatment condition (Po0.05). Total oral compressions per min (NNS þ nonNNS events) A significant main effect for treatment condition (SHAM vs PULSED) was found among preterm subjects independent of clinical group (Po0.05, d ¼ 0.41). For all preterm groups combined, this translates to a 17.2% increase from 71.7 to 81.3 oral compressions per min. CLD infants showed the most significant gains from the treatment with an increase of 22.2% from 74.07 in the SHAM condition to 90.53 oral compressions per min in the PULSED condition (Po0.01, d ¼ 0.50; Figure 5 ). Moreover, CLD babies outperformed HIs by 27% in the PULSED treatment condition by the margin 90.53 vs 71.30 oral compressions per min, respectively (Po0.05).
Mean NNS pressure No significant group effects, and no significant treatment effects emerged from the mixed model analysis.
Length of stay A significant group by treatment interaction effect was present (Po0.001). As shown in Figure 6 , CLD infants given the PULSED pacifier treatment stayed in the NICU for a significantly shorter period of time compared with CLD infants on the SHAM pacifier, by an average of 2.5 days less (Po0.05, d ¼ 0.39). On the other hand, RDS infants given the PULSED pacifier treatment remained in the NICU 4.3 days longer than RDS infants on the SHAM pacifier (Po0.01, d ¼ 0.47). Overall, both CLD and RDS infants remained in the NICU longer than their HI counterparts, (Po0.0001, d ¼ 0.69 and Po0.01, d ¼ 0.55, respectively).
DISCUSSION
The infant brain is a developing organ of enormous complexity, whose initial form is specified through genetic instruction, with pathway formation and network tuning subsequently modified and continuously refined by experience-and activity-dependent mechanisms. 19 Unfortunately, extrauterine life is a pathological condition for the premature infant, which greatly amplifies the challenges to the brain in establishing functional motor behaviors. 20 The brainstem suck central pattern generator in infants is responsive to peripheral input during this critical period of development 21 and adapts to changes in the local oral environment. 22, 23 The suck central pattern generator consists of networks of interneurons in the pontine and medullary reticular formation. These networks are premotor and influence lower motoneuron activity among trigeminal, facial, hypoglossal, glossopharyngeal and vagal nuclei. [24] [25] [26] In neurotypical infants, the NNS pattern is organized into alternating epochs of FM bursts and pause periods. An NNS burst consists of 2 to 12 suck cycles that initiate at approximately 2.9 Hz and exponentially decay to approximately 1.6 Hz followed by pause periods of variable length to accommodate respiration. 27 The results from this study expand on our previous work in RDS preterm infants and demonstrate the beneficial effects of a pneumatically pulsed pacifier nipple on the development of NNS in a larger and more diverse cohort of preterm infants with oromotor delays, including those with CLD. The pulsed orocutaneous experience has been enhanced to incorporate the FM characteristics of a neurotypical NNS burst. 27 This form of stimulation serves to entrain trigeminal mechanosensitive nerves in the lips, tongue and jaw of the neonate, which in turn influence the suck central pattern generator and oromotor activity. This approach is consistent with the role of sensorydriven neural activity in circuit formation and the notion that appropriate oral experiences may be critical in the final weeks of gestation in the formation of functional central neural circuits. 28 Use of an orocutaneous entrainment stimulus also has the distinct advantage of being safe and pleasurable for the neonate, and easily administered cribside by the care team in the NICU.
In general, somatosensory stimulation strategies have proven beneficial in developing oral feeding skills in premature infants. 15, 29 In a recent study, relatively brief tactile-motion stimulation (15 min, twice per day) applied to the face-mouth and body before tube feedings among 75 clinically stable preterm infants beginning at 32.3 weeks of PMA (26 to 32 weeks GA) resulted in the attainment of independent oral feeding approximately 9 to 10 days earlier than those in the control group. 30 This form of somatosensory stimulation also serves to improve the dynamics of swallow-respiration coordination. 31 Factors contributing to the development of CLD include immaturity of lung structure itself, prolonged oxygen and/or higher levels of respiratory support that cause free radicals exposure and damage to the developing lung, inflammatory cytokine cascades that may originate with maternal infection during pregnancy, and potentially genetic factors. As pulmonary function improves, these infants often manifest oromotor dyscoordination, absent or weak NNS, poor airway protection, dysphagia and poor state control. 32, 33 The invasiveness of lengthy intubation and oxygen supplementation procedures associated with prematurity and lung disease cost the baby precious sensory and motor experiences during a critical period of brain development for oromotor pattern generation. [34] [35] [36] [37] Even the presence of a nasogastric feeding tube has negative effects on sucking and breathing. 36 This translates to longer NICU stays until the infants achieve these life-essential skills. Therefore, it appears that preterm infants with significant lung disease may benefit from oral somatosensory therapy to improve their sucking and feeding skills. Preterm infants with significant lung disease have many reasons to explain their relative delays in sucking and feeding skills, and are therefore excellent candidates for oral somatosensory therapy to improve these skills.
The richness of the FM orocutaneous experience offered by a PULSED entrainment pacifier nipple presents a new and exciting neurotherapeutic application to promote suck and feeding skills. Exposure to this orosensory experience over the course of three gavage feeds per day for up to 10 days in the NICU provides the preterm infant with a neural entrainment experience that facilitates the development and strengthening of central pathways, which regulate suck. Recent evidence has shown the same PULSED orocutaneous stimulation, as used in this study, is highly effective in modulating brain activity as reflected in amplitude-integrated electroencephalogram and range-electroencephalogram measurements sampled in preterm infants at 32 weeks PMA. 38, 39 One unexpected finding in this study was the increased LOS for RDS infants who received the PULSED orocutaneous treatment and manifest significant NNS performance increases. One likely reason is the relatively late introduction of the PULSED orosensory treatment (B 34.5 weeks PMA). On average, RDS infants began extrauterine life a week earlier than their HI counterparts, and undoubtedly gained additional oromotor experience moving them ever closer to discharge from the NICU before our PULSED orocutaneous treatment was initiated. Future work with this population will introduce the PULSED orosensory treatment 10 to 14 days earlier which also is consistent with somatosensory stimulation strategies described in two recent papers. 30, 31 Another key question to be addressed in future studies concerns the dose of orocutaneous stimulation per gavage session and whether this should be adjusted in a progressive manner based on the infant's PMA and suck performance levels. For example, in our sicker preterm infants (that is, CLD), the administration of the third 3-min block of pulsed orocutaneous stimulation toward the end of a 20-min gavage feed was sometimes judged by the study nurse/coordinator to exceed the energy capacity of the infant to support NNS activity. This is an important observation as overstimulation of trigeminal afferents may negatively reinforce ororhythmic pattern formation. Our previous experience with RDS and preterm infants 40 utilized a single 3-min orosensory period, which was tolerated well by the majority of infants. Thus, it seems reasonable to consider a graduated oral somatosensory therapy schedule for preterm infants, based in part, on their medical diagnosis, motor capacity and experience. In this study, CLD infants had an average GA birth of approximately 27 0/7 weeks, and began orosensory entrainment therapy at approximately 35 5/7 weeks PMA, whereas RDS infants were in the womb 3 weeks longer with an average GA birth of 30 4/7 weeks, and began their entrainment therapy a week earlier at approximately 34 5/7 weeks PMA. In a graduated schedule, one could initiate the CLD infant with a single 3-min orosensory entrainment condition during three gavage sessions on days 1 and 2, and then increase to two 3-min orosensory entrainment conditions on successive days (for example, days 3 to 10). Preterm infants with somewhat more mature GAs at birth (for example, 30 weeks compared with 27 weeks) can be initiated at higher levels of orosensory entrainment therapy to promote NNS and ororythmic pattern stabilization.
The study results show a significant improvement in NNS in preterm infants with various degrees of illness through the use of the pulsed pacifier controlled by the NTrainer device. RDS and CLD babies increased several NNS performance measures as a result of the PULSED treatment condition. These findings may relate to the GA at birth, with the CLD babies being born at a younger average GA birth . This may also be a function of the very different NICU cares and therapies required in these babies. Brain development and responses to oral stimulation have different characteristics in these babies. Understanding these characteristics can lead to tailored clinical strategies, using the NTrainer device, according to the baby's clinical condition and history. Algorithms could be developed that could be specific for different disease states. The NTrainer device used in this study is easily used and is very portable. This study shows that the NTrainer device is promising as a potential therapeutic strategy for babies in NICU with various clinical disorders who need to develop oral feeding skills in order to be safely discharged home with adequate oral nutrition.
